Purple Biotech Latest News
- 03-12 AInvest WireGatx's 15min chart triggers KDJ Golden Cross, bullish signal with Bullish Marubozu candle.
- 03-11 AInvest ExclusivePPBT Latest Report
- 03-11 AInvest NewsFinancial Results | Purple Biotech 2024 Full Year Net Loss USD 7.28 Million
- 03-10 AInvest WirePurple Biotech Reports Q4 GAAP EPS of -$0.26, Cash Runway Extended to Mid-2026
- 03-10 AInvest WirePurple Biotech succeeds in clinical trials for CM24, NT219, and CAPTN-3 oncology assets.
- 03-10 NasdaqPurple Biotech Reports Fourth Quarter and Full-Year 2024 Financial Results
- 03-05 AInvest WireMalaysia Corporate News Recap: PPB, CIMB, Sunway Construction, and more
- 03-05 MarketWatchPurple Biotech Secures U.S. Patent for NT219 in Cancer Therapy
- 03-05 MarketWatchPurple Biotech granted new U.S. patent for NT219
- 03-05 AInvest WirePurple Biotech Secures New U.S. Patent for NT219 in Combination with EGFR Antibody Therapy.
- 03-05 NasdaqPurple Biotech Granted New U.S. Patent for NT219 in Combination with EGFR Antibody Therapy, Enhancing Global IP Protection in Major Markets
- 03-05 AInvest WirePPB Group anticipates steady performance from core business in 2025, driven by expertise in grain sourcing and technical capabilities.
- 02-28 AInvest WireTyler Technologies' 15min chart shows KDJ Golden Cross, bullish Marubozu pattern.
- 02-27 AInvest WireQuad/Graphics stock price surges with KDJ Golden Cross and bullish Marubozu pattern
- 02-26 AInvest WireGroup 1 Automotive's 15min chart shows KDJ Golden Cross, Bullish Marubozu
- 02-25 AInvest WireGatx 15min chart triggers KDJ Golden Cross, bullish Marubozu signal.
- 02-20 AInvest WireGreen Brick's 15min chart triggers KDJ Golden Cross, Bullish Marubozu signal.
- 02-19 AInvest WireGatx's 15-Minute Chart Shows Bullish Trend with KDJ Golden Cross and Marubozu
- 02-19 AInvest WirePurple Biotech Advances NT219 in Phase II Trial for R/M SCCHN Patients
- 02-18 MarketWatchPurple Biotech Advances NT219 into Phase 2 Cancer Trial
Show More News